1. Home
  2. STAA vs NBXG Comparison

STAA vs NBXG Comparison

Compare STAA & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • NBXG
  • Stock Information
  • Founded
  • STAA 1982
  • NBXG 2021
  • Country
  • STAA United States
  • NBXG United States
  • Employees
  • STAA N/A
  • NBXG N/A
  • Industry
  • STAA Ophthalmic Goods
  • NBXG Trusts Except Educational Religious and Charitable
  • Sector
  • STAA Health Care
  • NBXG Finance
  • Exchange
  • STAA Nasdaq
  • NBXG Nasdaq
  • Market Cap
  • STAA 1.4B
  • NBXG 1.1B
  • IPO Year
  • STAA N/A
  • NBXG N/A
  • Fundamental
  • Price
  • STAA $27.25
  • NBXG $15.37
  • Analyst Decision
  • STAA Hold
  • NBXG
  • Analyst Count
  • STAA 8
  • NBXG 0
  • Target Price
  • STAA $22.50
  • NBXG N/A
  • AVG Volume (30 Days)
  • STAA 674.6K
  • NBXG 243.7K
  • Earning Date
  • STAA 10-29-2025
  • NBXG 01-01-0001
  • Dividend Yield
  • STAA N/A
  • NBXG 10.25%
  • EPS Growth
  • STAA N/A
  • NBXG N/A
  • EPS
  • STAA N/A
  • NBXG N/A
  • Revenue
  • STAA $224,449,000.00
  • NBXG N/A
  • Revenue This Year
  • STAA N/A
  • NBXG N/A
  • Revenue Next Year
  • STAA $27.24
  • NBXG N/A
  • P/E Ratio
  • STAA N/A
  • NBXG N/A
  • Revenue Growth
  • STAA N/A
  • NBXG N/A
  • 52 Week Low
  • STAA $13.50
  • NBXG $9.31
  • 52 Week High
  • STAA $38.60
  • NBXG $12.23
  • Technical
  • Relative Strength Index (RSI)
  • STAA 57.35
  • NBXG 71.12
  • Support Level
  • STAA $26.98
  • NBXG $15.08
  • Resistance Level
  • STAA $28.13
  • NBXG $15.24
  • Average True Range (ATR)
  • STAA 0.47
  • NBXG 0.17
  • MACD
  • STAA -0.34
  • NBXG 0.04
  • Stochastic Oscillator
  • STAA 17.14
  • NBXG 98.81

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.

Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".

Share on Social Networks: